600624 logo

Shanghai Fudan Forward S&TXSSC:600624 Stock Report

Market Cap CN¥5.0b
Share Price
CN¥7.30
My Fair Value
AN
AnalystConsensusTarget
CN¥0.36
1.9k% overvalued intrinsic discount
1Y80.2%
7D4.3%
Portfolio Value
View

Shanghai Fudan Forward S&T Co., Ltd

XSSC:600624 Stock Report

Market Cap: CN¥5.0b

Shanghai Fudan Forward S&T (600624) Stock Overview

Operates in software development, biomedicine, real estate, and other businesses. More details

600624 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

600624 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Shanghai Fudan Forward S&T Co., Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for Shanghai Fudan Forward S&T
Historical stock prices
Current Share PriceCN¥7.30
52 Week HighCN¥9.50
52 Week LowCN¥2.76
Beta0.40
1 Month Change4.73%
3 Month Change17.74%
1 Year Change80.25%
3 Year Change8.96%
5 Year Change-25.20%
Change since IPO-13.30%

Recent News & Updates

Recent updates

Shareholder Returns

600624CN PharmaceuticalsCN Market
7D4.3%2.0%2.8%
1Y80.2%37.2%34.0%

Return vs Industry: 600624 exceeded the CN Pharmaceuticals industry which returned 37.2% over the past year.

Return vs Market: 600624 exceeded the CN Market which returned 34% over the past year.

Price Volatility

Is 600624's price volatile compared to industry and market?
600624 volatility
600624 Average Weekly Movement4.5%
Pharmaceuticals Industry Average Movement5.0%
Market Average Movement4.9%
10% most volatile stocks in CN Market8.5%
10% least volatile stocks in CN Market2.9%

Stable Share Price: 600624 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 600624's weekly volatility has decreased from 10% to 5% over the past year.

About the Company

FoundedEmployeesCEOWebsite
19841,414n/awww.forwardgroup.com

Shanghai Fudan Forward S&T Co., Ltd operates in software development, biomedicine, real estate, and other businesses. The company develops and exports software to Japan; and researches, develops, produces, and sells chemical drugs, Chinese patent medicines, freeze-dried powder injections, and solid preparations, as well as chemical raw materials, digestive system drugs, nervous system drugs, antineoplastic drugs, circulatory system drugs, and traditional and modern Chinese medicines. It is also involved in the development of high-tech parks; and development, production, and sale of uninterruptible power supplies and lead-acid batteries, as well as professional agent of car audio brand.

Shanghai Fudan Forward S&T Co., Ltd Fundamentals Summary

How do Shanghai Fudan Forward S&T's earnings and revenue compare to its market cap?
600624 fundamental statistics
Market capCN¥4.96b
Earnings (TTM)-CN¥130.23m
Revenue (TTM)CN¥650.76m
7.6x
P/S Ratio
-38.1x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600624 income statement (TTM)
RevenueCN¥650.76m
Cost of RevenueCN¥506.43m
Gross ProfitCN¥144.33m
Other ExpensesCN¥274.56m
Earnings-CN¥130.23m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Aug 30, 2025

Earnings per share (EPS)-0.19
Gross Margin22.18%
Net Profit Margin-20.01%
Debt/Equity Ratio61.2%

How did 600624 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/25 19:04
End of Day Share Price 2025/07/25 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shanghai Fudan Forward S&T Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.